Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction

Diabetes

Volumn 63, Issue 5, 2014, Pages 1698-1711

  Westwell Roper, Clara Y ^a   Ehses, Jan A ^a   Verchere, C Bruce ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CYTOKINES; DIABETES MELLITUS, TYPE 2; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; INTERLEUKIN-1BETA; ISLET AMYLOID POLYPEPTIDE; ISLETS OF LANGERHANS; MACROPHAGES; MICE; MICE, TRANSGENIC; OBESITY;

EID: 84894518230     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0863     Document Type: Article

References (58)

1. Hull RL, Westermark GT, Westermark P, Kahn SE. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 2004;89:3629-3643 (Pubitemid 39071447)
2. Ehses JA, Perren A, Eppler E, et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 2007;56:2356-2370 (Pubitemid 47358243)
3. Donath MY, Böni-Schnetzler M, Ellingsgaard H, Halban PA, Ehses JA. Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol Metab 2010;21:261-267
4. Masters SL, Dunne A, Subramanian SL, et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol 2010;11:897-904
5. Westwell-Roper C, Dai DL, Soukhatcheva G, et al. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 2011;187:2755-2765
6. Stewart CR, Stuart LM, Wilkinson K, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010;11:155-161
7. Masters SL, O'Neill LAJ. Disease-associated amyloid and misfolded protein aggregates activate the inflammasome. Trends Mol Med 2011;17:276-282
8. Mahdi T, Hänzelmann S, Salehi A, et al. Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes. Cell Metab 2012;16:625-633
9. Donath MY, Dalmas E, Sauter NS, Böni-Schnetzler M. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab 2013;17:860-872
10. Maedler K, Sergeev P, Ris F, et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002;110:851-860
11. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010;11:136-140
12. Ribaux P, Ehses JA, Lin-Marq N, et al. Induction of CXCL1 by extracellular matrix and autocrine enhancement by interleukin-1 in rat pancreatic beta-cells. Endocrinology 2007;148:5582-5590 (Pubitemid 350012633)
13. Böni-Schnetzler M, Thorne J, Parnaud G, et al. Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab 2008;93:4065-4074
14. Eguchi K, Manabe I, Oishi-Tanaka Y, et al. Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. Cell Metab 2012; 15:518-533
15. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA. IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest 1998;102:516-526 (Pubitemid 28376154)
16. Calderon B, Suri A, Miller MJ, Unanue ER. Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules. Proc Natl Acad Sci U S A 2008;105:6121-6126 (Pubitemid 351758409)
17. Yin N, Xu J, Ginhoux F, et al. Functional specialization of islet dendritic cell subsets. J Immunol 2012;188:4921-4930
18. Boillée S, Yamanaka K, Lobsiger CS, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006; 312:1389-1392 (Pubitemid 43839552)
19. Cameron B, Landreth GE. Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis 2010;37:503-509
20. de Koning EJ, van den Brand JJ, Mott VL, et al. Macrophages and pancreatic islet amyloidosis. Amyloid 1998;5:247-254
21. Janson J, Soeller WC, Roche PC, et al. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A 1996;93:7283-7288 (Pubitemid 26243541)
22. Soeller WC, Janson J, Hart SE, et al. Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes 1998;47:743-750 (Pubitemid 28201803)
23. Salvalaggio PRO, Deng S, Ariyan CE, et al. Islet filtration: a simple and rapid new purification procedure that avoids ficoll and improves islet mass and function. Transplantation 2002;74:877-879
24. Park K, Verchere CB. Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation. J Biol Chem 2001;276:16611-16616
25. Schneider CARW, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671-675
26. van Rooijen N, van Kesteren-Hendrikx E. "In vivo" depletion of macrophages by liposome-mediated "suicide". Methods Enzymol 2003;373:3-16
27. Spandidos A, Wang X, Wang H, Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res 2010;38(Database issue):D792-D799
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408 (Pubitemid 34164012)
29. Hutton MJ, Soukhatcheva G, Johnson JD, Verchere CB. Role of the TLR signaling molecule TRIF in β-cell function and glucose homeostasis. Islets 2010;2:104-111
30. Lacy PE, Finke EH. Activation of intraislet lymphoid cells causes destruction of islet cells. Am J Pathol 1991;138:1183-1190
31. Cao S, Zhang X, Edwards JP, Mosser DM. NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem 2006;281:26041-26050 (Pubitemid 44401810)
32. Smith MF Jr., Eidlen D, Arend WP, Gutierrez-Hartmann A. LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements. J Immunol 1994;153:3584-3593 (Pubitemid 24313862)
33. Hull RL, Andrikopoulos S, Verchere CB, et al. Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 2003;52:372-379 (Pubitemid 36173192)
34. Haluzik M, Colombo C, Gavrilova O, et al. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 2004;145:3258-3264 (Pubitemid 38829998)
35. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-964 (Pubitemid 41746764)
36. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175-184 (Pubitemid 46048464)
37. Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517-1526 (Pubitemid 46588416)
38. Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 2008;28:8354-8360
39. Arnush M, Scarim AL, Heitmeier MR, Kelly CB, Corbett JA. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol 1998;160:2684-2691 (Pubitemid 28136719)
40. Markmann JF, Jacobson JD, Kiumura H, et al. Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts. Transplantation 1989;48:478-486 (Pubitemid 19236518)
41. Rabinovitch A, Alejandro R, Noel J, Brunschwig JP, Ryan US. Tissue culture reduces Ia antigen-bearing cells in rat islets and prolongs islet allograft survival. Diabetes 1982;31(Suppl. 4):48-54 (Pubitemid 12098712)
42. Heitmeier MR, Arnush M, Scarim AL, Corbett JA. Pancreatic beta-cell damage mediated by beta-cell production of interleukin-1. A novel mechanism for virus-induced diabetes. J Biol Chem 2001;276:11151-11158 (Pubitemid 38089298)
43. Sheykhzade M, Nyborg NC. Non-competitive antagonism of amylin on CGRP(1)-receptors in rat coronary small arteries. Br J Pharmacol 2000;130:386-390 (Pubitemid 30261050)
44. Shi XX, Wang LL, Li XX, Sahbaie PP, Kingery WSW, Clark JDJ. Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1b production in keratinocytes. Anesth Analg 2011;113:175-183
45. Manczak M, Mao P, Nakamura K, Bebbington C, Park B, Reddy PH. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease. Hum Mol Genet 2009;18: 3876-3893
46. Taylor-Fishwick DA, Weaver JR, Grzesik W, et al. Production and function of IL-12 in islets and beta cells. Diabetologia 2013;56:126-135
47. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995;270:9558-9563
48. Sunderkötter C, Nikolic T, Dillon MJ, et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004;172:4410-4417 (Pubitemid 38375256)
49. Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990;75:1037-1050 (Pubitemid 20086807)
50. Oh DYD, Morinaga HH, Talukdar SS, Bae EJE, Olefsky JMJ. Increased macrophage migration into adipose tissue in obese mice. Diabetes 2012;61:346-354
51. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005;175:342-349 (Pubitemid 40884337)
52. Cucak H, Grunnet LG, Rosendahl A. Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macrophage polarization. J Leukoc Biol. 5 September 2013 [Epub ahead of print]
53. Lee YS, Li P, Huh JY, et al. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 2011;60:2474-2483
54. Zraika S, Hull RL, Udayasankar J, et al. Glucose- and time-dependence of islet amyloid formation in vitro. Biochem Biophys Res Commun 2007;354:234-239 (Pubitemid 46123224)
55. Badman MK, Pryce RA, Chargé SB, Morris JF, Clark A. Fibrillar islet amyloid polypeptide (amylin) is internalised by macrophages but resists proteolytic degradation. Cell Tissue Res 1998;291:285-294 (Pubitemid 28081852)
56. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 1999;48:491-498 (Pubitemid 29106861)
57. Maedler K, Schumann DM, Sauter N, et al. Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes 2006;55:2713-2722 (Pubitemid 44923669)
58. Ribaux P, Ehses JA, Lin-Marq N, et al. Induction of CXCL1 by extracellular matrix and autocrine enhancement by interleukin-1 in rat pancreatic beta-cells. Endocrinology 2007;148:5582-5590 (Pubitemid 350012633)